Safer canes and crutches
The biomechanical features of the human ankle inspired the design of a new safety tip called Fedrofuss.
Therapy
High-cal intake: Hope for bowel cancer?
France - Less than 50% of those affected by bowel cancer survive beyond five years after diagnosis. However, new research* surprisingly suggests that a high calorie diet may increase chances of survival for longer.
The high cost of bipolar disorder
The most expensive behavioural healthcare diagnosis, for sufferers and their insurers, is bipolar disorder, according to a study published in the American Journal of Psychiatry (160:1286-1290, July 2003).
Web advisories aid physicians
Monitoring and rapidly introducing new developments into everyday practice is an increasingly difficult task for many doctors. Additionally, patients are more informed due to media medical reports, which raise their expectations that doctors can offer a quick, reliable interpretation of the latest medical data.
CE approved
The Biotronik Home Monitoring Service, which gained CE approval in May, has now monitored over 1,500 patients worldwide. Studies indicate that 88% of patients claim an increased sense of security due to the service.
Stimulating cell metabolism
G-ogo sport, a new innovation from Dr. Goettfert Systems, uses a pulsing magnetic field to stimulate cell metabolism.
Precision radio therapy
Professor Wolfgang Schlegel, Head of the Department of Medical Physics at the German Cancer Research Centre, has been awarded the 2003 clinical section of the German Cancer Award, for significantly improving the precision with which radiation beams can be directed at a tumour.
Hormone-resistant prostate cancer
Prostate cancer, the most common neoplasm in men, often progresses from an androgen-dependant state (and is commonly treated by androgen ablation therapies) to a hormone-refractory stage, therefore making hormone therapy ineffective. The response duration to androgen ablation therapy is finite and ultimately most prostate cancer will become hormone-insensitive.